During the past decade, M.A. - LEK A.M.Maciejowscy SC. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "M.A. - LEK A.M.Maciejowscy SC." #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Biogen" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "M.A. - LEK A.M.Maciejowscy SC." #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "M.A. - LEK A.M.Maciejowscy SC." are "Multiple Sclerosis" (10 trials), "Relapsing Multiple Sclerosis" (2 trials), "Alzheimer's Disease" (1 trials), "Focal Onset Seizures" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "M.A. - LEK A.M.Maciejowscy SC." in a lesser frequency.

Most popular intervention types in "M.A. - LEK A.M.Maciejowscy SC." are "Drug" (19 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ocrelizumab" (6 trials), "Interferon beta-1a" (3 trials), "Antihistamine" (2 trials) and "Interferon beta-1a-matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "M.A. - LEK A.M.Maciejowscy SC." are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "M.A. - LEK A.M.Maciejowscy SC.". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in M.A. - LEK A.M.Maciejowscy SC., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in M.A. - LEK A.M.Maciejowscy SC., 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".